NPC-15669

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNPC-15669
Drug Alias NameNPC-15669
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-M/beta-2 antagonists
TargetsIntegrin alpha-M/beta-2
Therapy Area/IndicationsAtherosclerosisIrritable Bowel SyndromeShock, Septic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsAtherosclerosisIrritable Bowel SyndromeShock, Septic

Other Information

ATC CodeN/A
Related LinksN/A